Localization of CGRP, CGRP receptor, PACAP and glutamate in trigeminal ganglion. Relation to the blood-brain barrier

Brain Research

Volumn 1600, Issue , 2015, Pages 93-109

  Eftekhari, Sajedeh ^a   Salvatore, Christopher A ^b   Johansson, Sara ^c   Chen, Tsing Bau ^b   Zeng, Zhizhen ^b   Edvinsson, Lars ^a,c  

^a LUND UNIVERSITY   (Sweden)

^b MERCK RESEARCH LABORATORIES   (United States)

^c GLOSTRUP UNIVERSITY HOSPITAL   (Denmark)

Author keywords

CGRP; CGRP receptor antagonists; CLR; Evans blue; RAMP1; Trigeminal ganglion

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CALCITONIN GENE RELATED PEPTIDE RECEPTOR; CALCITONIN RECEPTOR LIKE RECEPTOR; GLUTAMIC ACID; HYPOPHYSIS ADENYLATE CYCLASE ACTIVATING POLYPEPTIDE; RECEPTOR ACTIVITY MODIFYING PROTEIN 1; 2-(8-(3,5-DIFLUOROPHENYL)-10-OXO-6,9-DIAZASPIRO(4.5)DEC-9-YL)-N-(2'-OXO-1,1',2',3-TETRAHYDROSPIRO(INDENE-2,3'-PYRROLO(2,3-B)PYRIDIN)-5-YL)ACETAMIDE; FUSED HETEROCYCLIC RINGS; SPIRO COMPOUND;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BINDING SITE; BLOOD BRAIN BARRIER; CONTROLLED STUDY; IMMUNOFLUORESCENCE; MALE; NERVE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; RECEPTOR BINDING; TRIGEMINUS GANGLION; ANIMAL; ANTAGONISTS AND INHIBITORS; FEMALE; METABOLISM; RHESUS MONKEY; SCINTISCANNING; SPRAGUE DAWLEY RAT;

RATTUS;

ANIMALS; BICYCLO COMPOUNDS, HETEROCYCLIC; BLOOD-BRAIN BARRIER; CALCITONIN GENE-RELATED PEPTIDE; CALCITONIN RECEPTOR-LIKE PROTEIN; FEMALE; GLUTAMIC ACID; MACACA MULATTA; MALE; NEURONS; PITUITARY ADENYLATE CYCLASE-ACTIVATING POLYPEPTIDE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR ACTIVITY-MODIFYING PROTEIN 1; RECEPTORS, CALCITONIN GENE-RELATED PEPTIDE; SPIRO COMPOUNDS; TRIGEMINAL GANGLION;

EID: 84923335592     PISSN: 00068993     EISSN: 18726240     Source Type: Journal    
DOI: 10.1016/j.brainres.2014.11.031     Document Type: Article

References (82)

1. F.J. Alvarez, H.R. Morris, and J.V. Priestley Sub-populations of smaller diameter trigeminal primary afferent neurons defined by expression of calcitonin gene-related peptide and the cell surface oligosaccharide recognized by monoclonal antibody LA4 J. Neurocytol. 20 1991 716 731
2. F.M. Amin, M.S. Asghar, S. Guo, A. Hougaard, A.E. Hansen, H.W. Schytz, R.J. van der Geest, P.J. de Koning, H.B. Larsson, J. Olesen, and M. Ashina Headache and prolonged dilatation of the middle meningeal artery by PACAP38 in healthy volunteers Cephalalgia 32 2012 140 149
3. F.M. Amin, M.S. Asghar, A. Hougaard, A.E. Hansen, V.A. Larsen, P.J. de Koning, H.B. Larsson, J. Olesen, and M. Ashina Magnetic resonance angiography of intracranial and extracranial arteries in patients with spontaneous migraine without aura: a cross-sectional study Lancet Neurol. 12 2013 454 461
4. A.P. Andreou, and P.J. Goadsby Therapeutic potential of novel glutamate receptor antagonists in migraine Expert Opin. Investig. Drugs 18 2009 789 803
5. B. Arvidsson, K. Kristensson, and Y. Olsson Vascular permeability to fluorescent protein tracer in trigeminal nerve and gasserian ganglion Acta Neuropathol. 26 1973 199 205
6. I.M. Bell, S.N. Gallicchio, M.R. Wood, A.G. Quigley, C.A. Stump, C.B. Zartman, J.F. Fay, C.C. Li, J.J. Lynch, E.L. Moore, S.D. Mosser, T. Prueksaritanont, C.P. Regan, S. Roller, C.A. Salvatore, S.A. Kane, J.P. Vacca, and H.G. Selnick Discovery of MK-3207: a highly potent, orally bioavailable CGRP receptor antagonist ACS Med. Chem. Lett. 1 2010 24 29
7. J.L. Bellamy, R.K. Cady, and P.L. Durham Salivary levels of CGRP and VIP in rhinosinusitis and migraine patients Headache 46 2006 24 33
8. D.K. Bhatt, S. Gupta, K.B. Ploug, I. Jansen-Olesen, and J. Olesen mRNA distribution of CGRP and its receptor components in the trigeminovascular system and other pain related structures in rat brain, and effect of intracerebroventricular administration of CGRP on Fos expression in the TNC Neurosci. Lett. 559 2014 99 104
9. M.E. Bigal, S. Walter, and A.M. Rapoport Calcitonin gene-related peptide (CGRP) and migraine current understanding and state of development Headache 53 2013 1230 1244
10. D. Borsook, R. Burstein, E. Moulton, and L. Becerra Functional imaging of the trigeminal system: applications to migraine pathophysiology Headache 46 Suppl. 1 2006 S32 S38
11. E. Cernuda-Morollon, D. Larrosa, C. Ramon, J. Vega, P. Martinez-Camblor, and J. Pascual Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine Neurology 81 14:1191-1196 2013
12. K. Chan, L. Edvinsson, S. Eftekhari, P.O. Kimblad, S. Kane, J. Lynch, R. Hargreaves, R. de Vries, I. Garrelds, A. van den Bogaerdt, J. Danser, and A. Maassenvandenbrink Characterization of the CGRP receptor antagonist telcagepant (MK-0974) in human isolated coronary arteries J. Pharmacol. Exp. Ther. 334:746-752 2010
13. A. Charles Migraine: a brain state Curr. Opin. Neurol. 26 2013 235 239
14. A. de Corato, A. Capuano, D. Curro, G. Tringali, P. Navarra, and C. Dello Russo Trigeminal satellite cells modulate neuronal responses to triptans: relevance for migraine therapy Neuron Glia Biol. 7 2011 109 116
15. A. Dieterle, M.J. Fischer, A.S. Link, W.L. Neuhuber, and K. Messlinger Increase in CGRP- and nNOS-immunoreactive neurons in the rat trigeminal ganglion after infusion of an NO donor Cephalalgia 31 2011 31 42
16. E. Dolgin Antibody drugs set to revive flagging migraine target Nat. Rev. Drug Discov. 12 2013 249 250
17. P.L. Durham, and C.V. Vause Calcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraine CNS Drugs 24 2010 539 548
18. L. Edvinsson PACAP and its receptors in migraine pathophysiology Br. J. Pharmacol 10.1111/bph.12772 2014
19. L. Edvinsson, K.Y. Chan, S. Eftekhari, E. Nilsson, R. de Vries, H. Saveland, C.M. Dirven, A.H. Danser, and A. MaassenVanDenBrink Effect of the calcitonin gene-related peptide (CGRP) receptor antagonist telcagepant in human cranial arteries Cephalalgia 30 2010 1233 1240
20. L. Edvinsson, T. Elsas, N. Suzuki, T. Shimizu, and T.J. Lee Origin and Co-localization of nitric oxide synthase, CGRP, PACAP, and VIP in the cerebral circulation of the rat Microsc. Res. Tech. 53 2001 221 228
21. L. Edvinsson, and P.J. Goadsby Extracerebral manifestations in migraine. A peptidergic involvement? J. Intern. Med. 228 1990 299 304
22. L. Edvinsson, and M. Linde New drugs in migraine treatment and prophylaxis: telcagepant and topiramate Lancet 376 2010 645 655
23. L. Edvinsson, E. Nilsson, and I. Jansen-Olesen Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery Br. J. Pharmacol. 150 2007 633 640
24. L.1 Edvinsson, and P. Tfelt-Hansen The blood-brain barrier in migraine treatment Cephalalgia 12 2008 1245 1258
25. S. Eftekhari, and L. Edvinsson Possible sites of action of the new calcitonin gene-related peptide receptor antagonists Ther. Adv. Neurol. Disord. 3 2010 369 378
26. S. Eftekhari, R. Gaspar, R. Roberts, S. Villarreal, T. Chen, Z. Zeng, L. Edvinsson, and C. Salvatore Localization of CGRP receptor components, CGRP and receptor binding sites in rhesus brainstem: a detailed study using in situ hybridization and autoradiography Cephalalgia 2013 2013 33 (Supplement)
27. S. Eftekhari, C.A. Salvatore, A. Calamari, S.A. Kane, J. Tajti, and L. Edvinsson Differential distribution of calcitonin gene-related peptide and its receptor components in the human trigeminal ganglion Neuroscience 169 2010 683 696
28. S. Eftekhari, C.A. Salvatore, R.C. Gaspar, R. Roberts, S. O'Malley, Z. Zeng, and L. Edvinsson Localization of CGRP receptor components, CGRP, and receptor binding sites in human and rhesus cerebellar cortex Cerebellum 12 2013 937 949
29. S. Eftekhari, K. Warfvinge, F.W. Blixt, and L. Edvinsson Differentiation of nerve fibers storing CGRP and CGRP receptors in the peripheral trigeminovascular system J. Pain 14 2013 1289 1303
30. P.J. Goadsby Recent advances in understanding migraine mechanisms, molecules and therapeutics Trends Mol. Med. 13 2007 39 44
31. P.J. Goadsby Pathophysiology of migraine Ann. Indian Acad. Neurol. 15 2012 S15 S22
32. P.J. Goadsby, and L. Edvinsson The trigeminovascular system and migraine: studies characterizing cerebrovascular and neuropeptide changes seen in humans and cats Ann. Neurol. 33 1993 48 56
33. P.J. Goadsby, L. Edvinsson, and R. Ekman Release of vasoactive peptides in the extracerebral circulation of humans and the cat during activation of the trigeminovascular system Ann. Neurol. 23 1988 193 196
34. P.J. Goadsby, L. Edvinsson, and R. Ekman Vasoactive peptide release in the extracerebral circulation of humans during migraine headache Ann. Neurol. 28 1990 183 187
35. Y. Gursoy-Ozdemir, J. Qiu, N. Matsuoka, H. Bolay, D. Bermpohl, and H.e.t. Jin Cortical spreading depression activates and upregulates MMP-9 J. Clin. Invest. 113 2004 1447 1455
36. J.M. Hansen, A.W. Hauge, J. Olesen, and M. Ashina Calcitonin gene-related peptide triggers migraine-like attacks in patients with migraine with aura Cephalalgia 30 2010 1179 1186
37. T.W. Ho, L. Edvinsson, and P.J. Goadsby CGRP and its receptors provide new insights into migraine pathophysiology Nat. Rev. Neurol. 6 2010 573 582
38. T.W. Ho, M.D. Ferrari, D.W. Dodick, V. Galet, J. Kost, X. Fan, H. Leibensperger, S. Froman, C. Assaid, C. Lines, H. Koppen, and P.K. Winner Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: a randomised, placebo-controlled, parallel-treatment trial Lancet 372 2008 2115 2123
39. T.W. Ho, L.K. Mannix, X. Fan, C. Assaid, C. Furtek, C.J. Jones, C.R. Lines, and A.M. Rapoport Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine Neurology 70 2008 1304 1312
40. E.D. Hostetler, A.D. Joshi, S. Sanabria-Bohorquez, H. Fan, Z. Zeng, M. Purcell, L. Gantert, K. Riffel, M. Williams, S. O'Malley, P. Miller, H.G. Selnick, S.N. Gallicchio, I.M. Bell, C.A. Salvatore, S.A. Kane, C.C. Li, R.J. Hargreaves, T. de Groot, G. Bormans, A. Van Hecken, I. Derdelinckx, J. de Hoon, T. Reynders, R. Declercq, I. De Lepeleire, W.P. Kennedy, R. Blanchard, E.E. Marcantonio, C. Sur, J.J. Cook, K. Van Laere, and J.L. Evelhoch In vivo quantification of calcitonin gene-related peptide receptor occupancy by telcagepant in rhesus monkey and human brain using the positron emission tomography tracer [11C]MK-4232 J. Pharmacol. Exp. Ther. 347 2013 478 486
41. M. Hou, M. Kanje, J. Longmore, J. Tajti, R. Uddman, and L. Edvinsson 5-HT(1B) and 5-HT(1D) receptors in the human trigeminal ganglion: co-localization with calcitonin gene-related peptide, substance P and nitric oxide synthase Brain Res. 909 2001 112 120
42. P. Joshi, C. Anderson, H. Binch, S. Hadida, S. Yoo, D. Bergeron, C. Decker, E. Terhaar, J. Moore, M. Garcia-Guzman, and A. Termin Identification of potent CNS-penetrant thiazolidinones as novel CGRP receptor antagonists Bioorg. Med. Chem. Lett. 24 2014 845 849
43. M.A. Kai-Kai, and R. Howe Glutamate-immunoreactivity in the trigeminal and dorsal root ganglia, and intraspinal neurons and fibres in the dorsal horn of the rat Histochem. J. 23 1991 171 179
44. E.A. Kaiser, and A.F. Russo CGRP and migraine: could PACAP play a role too? Neuropeptides 47 2013 451 461
45. H. Kaube, K.L. Hoskin, and P.J. Goadsby Inhibition by sumatriptan of central trigeminal neurones only after blood-brain barrier disruption Br. J. Pharmacol. 109 1993 788 792
46. J.A. Kiernan Vascular permeability in the peripheral autonomic and somatic nervous systems: controversial aspects and comparisons with the blood-brain barrier Microsc. Res. Tech. 35 1996 122 136
47. J.K. Lennerz, V. Ruhle, E.P. Ceppa, W.L. Neuhuber, N.W. Bunnett, E.F. Grady, and K. Messlinger Calcitonin receptor-like receptor (CLR), receptor activity-modifying protein 1 (RAMP1), and calcitonin gene-related peptide (CGRP) immunoreactivity in the rat trigeminovascular system: differences between peripheral and central CGRP receptor distribution J. Comp. Neurol. 507 2008 1277 1299
48. D. Levy, R. Burstein, and A.M. Strassman Calcitonin gene-related peptide does not excite or sensitize meningeal nociceptors: implications for the pathophysiology of migraine Ann. Neurol. 58 5 2005 698 705
49. J. Li, C.V. Vause, and P.L. Durham Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cells Brain Res. 1196 2008 22 32
50. Liu Y, Broman J, Zhang M, Edvinsson L 2009. Brainstem and thalamic projections from a craniovascular sensory nervous centre in the rostral cervical spinal dorsal horn of rats. Cephalalgia 29:935-948.
51. L.Y. Liu-Chen, T.M. Liszczak, J.C. King, and M.A. Moskowitz Immunoelectron microscopic study of substance P-containing fibers in feline cerebral arteries Brain Res. 369 1986 12 20
52. V. Limmroth, Z. Katsarava, B. Liedert, H. Guehring, K. Schmitz, H.C. Diener, and M.C. Michel An in vivo rat model to study calcitonin gene related peptide release following activation of the trigeminal vascular system Pain 92 2001 101 106
53. J.C. Marin, and P.J. Goadsby Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine? Expert Opin. Investig. Drugs 19 2010 555 561
54. I. Merchenthaler Neurons with access to the general circulation in the central nervous system of the rat: a retrograde tracing study with fluoro-gold Neuroscience 44 1991 655 662
55. K. Moller, Y.Z. Zhang, R. Hakanson, A. Luts, B. Sjolund, R. Uddman, and F. Sundler Pituitary adenylate cyclase activating peptide is a sensory neuropeptide: immunocytochemical and immunochemical evidence Neuroscience 57 1993 725 732
56. E.L. Moore, and C.A. Salvatore Targeting a family B GPCR/RAMP receptor complex: CGRP receptor antagonists and migraine Br. J. Pharmacol. 166 2012 66 78
57. J.L. Morris, P. Konig, T. Shimizu, P. Jobling, and I.L. Gibbins Most peptide-containing sensory neurons lack proteins for exocytotic release and vesicular transport of glutamate J. Comp. Neurol. 483 2005 1 16
58. A. Negro, L. Lionetto, M. Simmaco, and P. Martelletti CGRP receptor antagonists: an expanding drug class for acute migraine? Expert Opin. Investig. Drugs 21 2012 807 818
59. K. Nozaki, Y. Uemura, S. Okamoto, H. Kikuchi, and N. Mizuno Origins and distribution of cerebrovascular nerve fibers showing calcitonin gene-related peptide-like immunoreactivity in the major cerebral artery of the dog J. Comp. Neurol. 297 1990 219 226
60. J. Olesen, H.C. Diener, I.W. Husstedt, P.J. Goadsby, D. Hall, U. Meier, S. Pollentier, and L.M. Lesko Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine N. Engl. J. Med. 350 2004 1104 1110
61. A. Ottosson, and L. Edvinsson Release of histamine from dural mast cells by substance P and calcitonin gene-related peptide Cephalalgia 17 1997 166 174
62. J. Pascual, and P. Munoz Correlation between lipophilicity and triptan outcomes Headache 45 2005 3 6
63. A.C. Raddant, and A.F. Russo Calcitonin gene-related peptide in migraine: intersection of peripheral inflammation and central modulation Expert Rev. Mol. Med. 13 2011 e36
64. J.F. Rothrock, K.R. Mar, T.L. Yaksh, A. Golbeck, and A.C. Moore Cerebrospinal fluid analyses in migraine patients and controls Cephalalgia 15 1995 489 493
65. C.A. Salvatore, and S.A. Kane CGRP receptor antagonists: toward a novel migraine therapy Curr. Pharm. Biotechnol. 12 2011 1671 1680
66. C.A. Salvatore, E.L. Moore, A. Calamari, J.J. Cook, M.S. Michener, S. O'Malley, P.J. Miller, C. Sur, D.L. Williams Jr., Z. Zeng, A. Danziger, J.J. Lynch, C.P. Regan, J.F. Fay, Y.S. Tang, C.C. Li, N.T. Pudvah, R.B. White, I.M. Bell, S.N. Gallicchio, S.L. Graham, H.G. Selnick, J.P. Vacca, and S.A. Kane Pharmacological properties of MK-3207, a potent and orally active calcitonin gene-related peptide receptor antagonist J. Pharmacol. Exp. Ther. 333 2010 152 160
67. H.W. Schytz, S. Birk, T. Wienecke, C. Kruuse, J. Olesen, and M. Ashina PACAP38 induces migraine-like attacks in patients with migraine without aura Brain 132 2009 16 25
68. K. Seiler, J.I. Nusser, J.K. Lennerz, W.L. Neuhuber, and K. Messlinger Changes in calcitonin gene-related peptide (CGRP) receptor component and nitric oxide receptor (sGC) immunoreactivity in rat trigeminal ganglion following glyceroltrinitrate pretreatment J. Headache Pain 14 2013 74
69. T. Sprenger, and P.J. Goadsby Migraine pathogenesis and state of pharmacological treatment options BMC Med. 7 2009 71
70. J. Tajti, R. Uddman, and L. Edvinsson Neuropeptide localization in the "migraine generator" region of the human brainstem Cephalalgia 21 2001 96 101
71. J. Tajti, R. Uddman, S. Moller, F. Sundler, and L. Edvinsson Messenger molecules and receptor mRNA in the human trigeminal ganglion J. Auton. Nerv. Syst. 76 1999 176 183
72. M.P. Ten Tusscher, J. Klooster, and G.F. Vrensen Satellite cells as blood-ganglion cell barrier in autonomic ganglia Brain Res. 490 1989 95 102
73. S.H. Tsai, J.M. Tew, J.H. McLean, and M.T. Shipley Cerebral arterial innervation by nerve fibers containing calcitonin gene-related peptide (CGRP): I. Distribution and origin of CGRP perivascular innervation in the rat J. Comp. Neurol. 271 1988 435 444
74. B. Tuka, Z. Helyes, A. Markovics, T. Bagoly, J. Szolcsanyi, N. Szabo, E. Toth, Z.T. Kincses, L. Vecsei, and J. Tajti Alterations in PACAP-38-like immunoreactivity in the plasma during ictal and interictal periods of migraine patients Cephalalgia 33 2013 1085 1095
75. R. Uddman, J. Tajti, M. Hou, F. Sundler, and L. Edvinsson Neuropeptide expression in the human trigeminal nucleus caudalis and in the cervical spinal cord C1 and C2 Cephalalgia 22 2002 112 116
76. C.S. Walker, and D.L. Hay CGRP in the trigeminovascular system: a role for CGRP, adrenomedullin and amylin receptors? Br. J. Pharmacol, Dec 2013; 170(7): 1293-1307 2013
77. D. Vaudry, A. Falluel-Morel, S. Bourgault, M. Basille, D. Burel, O. Wurtz, A. Fournier, B.K. Chow, H. Hashimoto, L. Galas, and H. Vaudry Pituitary adenylate cyclase-activating polypeptide and its receptors: 20 years after the discovery Pharmacol. Rev. 61 2009 283 357
78. C.V. Vause, and P.L. Durham Calcitonin gene-related peptide differentially regulates gene and protein expression in trigeminal glia cells: findings from array analysis Neurosci. Lett. 473 2010 163 167
79. Vermeersch S.D., De Saint-Huber B., Derdelinckx I.P.K., Stekers M.S.K., Bormans G., Reynders T., Declercq R., De Lepeleire I., Kennedy W.D., Blancard R., Marcantonio E., Hargreaves R.Li C.-C., Sanabria S., Hosteöer E., Joshi A.Evelhoch J.Van Laere K., (2012). PET imaging in healty subjects and migraineurs suggests CGRP receptor antagonists do not have to act centrally to achieve clinical efficacy. In: European Headache and Migraine Trust International Congress, London, 20-23 September 2012, Poster number LB08 2012.
80. M. Vikelis, and D.D. Mitsikostas The role of glutamate and its receptors in migraine CNS Neurol. Disord. Drug Targets 6 2007 251 257
81. Y. Xiao, J.A. Richter, and J.H. Hurley Release of glutamate and CGRP from trigeminal ganglion neurons: role of calcium channels and 5-HT1 receptor signaling Mol. Pain. 4 2008 12
82. Z. Zhang, C.S. Winborn, B. Marquez de Prado, and A.F. Russo Sensitization of calcitonin gene-related peptide receptors by receptor activity-modifying protein-1 in the trigeminal ganglion J. Neurosci. 27 2007 2693 2703